Uremic Pruritis in Patients of End Stage Renal Disease on Thrice-Weekly Hemodialysis

Authors

  • Ayousha Burki
  • Shahid Anwar
  • Mateen Akram
  • Abad-ur-Rehman Awan
  • Hafiz Tahir Usman
  • Zahid Anwar

DOI:

https://doi.org/10.53350/pjmhs22162353

Keywords:

Uremic pruritis, Hemodialusis, End stage renal disease

Abstract

Objective: To determine the frequency of uremic pruritus in ESRD patients on thrice-weekly maintenance hemodialysis.

Study Design: Cross-sectional analytical study

Place and Duration of Study: Department of Nephrology, Sir Ganga Ram Hospital, Lahore from 1st Mar 2018 to 15th February 2019.

Methodology: Sixty five adult patients on hemodialysis for >3 months duration were included whereas patients on hemodialysis for acute kidney injury duration <3 months and exhibiting clinical or laboratory features of other conditions as chronic skin disease, cholestasis, and malignancies were excluded from the study.

Results: The mean age was 48±13.29 years, 46 (70.8%) were males and 19 (29.2%) were females. The mean BMI of patients was 23.73 kg/m2. Thirty one (47.1%) was diabetics and 34(52.9%) was nondiabetics. Hypertension was found in 61(93.9%) while 4(6.2%) were normotensive, 3 (4.6%) were on HD from 6 months to 1 year, while 19(29.4%), 43(66.0%) were on HD for 1 to 3 years and >3 years respectively.

Conclusion: The frequency of uremic pruritis in patients on thrice-weekly MHD is 23.1% in our population.

Downloads

How to Cite

Burki, A. ., Anwar, S. ., Akram, M. ., Awan, A.- ur-R. ., Usman, H. T. ., & Anwar, Z. . (2022). Uremic Pruritis in Patients of End Stage Renal Disease on Thrice-Weekly Hemodialysis. Pakistan Journal of Medical & Health Sciences, 16(02), 353. https://doi.org/10.53350/pjmhs22162353

Issue

Vol. 16 No. 02 (2022): Pakistan Journal of Medical & Health Sciences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.